Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems. The company also provides microbiological and analytical chemistry testing, as well as technical assistance, regulatory consulting, and advisory services. It serves medical devices, pharmaceuticals, food safety, agricultural products, cancer treatment, and high-performance materials industries, as well as commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio. more
Time Frame | SHC | Sector | S&P500 |
---|---|---|---|
1-Week Return | -2.33% | -3.72% | -0.05% |
1-Month Return | -6.41% | -1.85% | 2.75% |
3-Month Return | -23.18% | -11.4% | 7.4% |
6-Month Return | 14.35% | -4.41% | 10.47% |
1-Year Return | -19.12% | 4.13% | 27.57% |
3-Year Return | -38.23% | 0.3% | 29.56% |
5-Year Return | -48.25% | 36.62% | 89.3% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 778.33M | 818.16M | 931.48M | 1.00B | 1.05B | [{"date":"2019-12-31","value":74.18,"profit":true},{"date":"2020-12-31","value":77.97,"profit":true},{"date":"2021-12-31","value":88.77,"profit":true},{"date":"2022-12-31","value":95.65,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 382.90M | 374.59M | 412.81M | 446.68M | 472.13M | [{"date":"2019-12-31","value":81.1,"profit":true},{"date":"2020-12-31","value":79.34,"profit":true},{"date":"2021-12-31","value":87.43,"profit":true},{"date":"2022-12-31","value":94.61,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 395.43M | 443.57M | 518.67M | 557.00M | 577.16M | [{"date":"2019-12-31","value":68.51,"profit":true},{"date":"2020-12-31","value":76.85,"profit":true},{"date":"2021-12-31","value":89.87,"profit":true},{"date":"2022-12-31","value":96.51,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 50.81% | 54.22% | 55.68% | 55.50% | 55.00% | [{"date":"2019-12-31","value":91.24,"profit":true},{"date":"2020-12-31","value":97.37,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":99.66,"profit":true},{"date":"2023-12-31","value":98.78,"profit":true}] |
Operating Expenses | 206.04M | 237.55M | 261.94M | 308.65M | 300.47M | [{"date":"2019-12-31","value":66.76,"profit":true},{"date":"2020-12-31","value":76.96,"profit":true},{"date":"2021-12-31","value":84.86,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":97.35,"profit":true}] |
Operating Income | 183.60M | 206.02M | 256.73M | 248.35M | 276.69M | [{"date":"2019-12-31","value":66.35,"profit":true},{"date":"2020-12-31","value":74.46,"profit":true},{"date":"2021-12-31","value":92.79,"profit":true},{"date":"2022-12-31","value":89.76,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Total Non-Operating Income/Expense | (342.24M) | (460.14M) | (155.21M) | (571.61M) | (303.16M) | [{"date":"2019-12-31","value":-34224200000,"profit":false},{"date":"2020-12-31","value":-46013700000,"profit":false},{"date":"2021-12-31","value":-15520900000,"profit":false},{"date":"2022-12-31","value":-57160500000,"profit":false},{"date":"2023-12-31","value":-30315900000,"profit":false}] |
Pre-Tax Income | (916.00K) | (38.86M) | 175.72M | (243.11M) | 106.03M | [{"date":"2019-12-31","value":-0.52,"profit":false},{"date":"2020-12-31","value":-22.12,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-138.35,"profit":false},{"date":"2023-12-31","value":60.34,"profit":true}] |
Income Taxes | 19.51M | (1.37M) | 58.59M | (9.54M) | 54.65M | [{"date":"2019-12-31","value":33.29,"profit":true},{"date":"2020-12-31","value":-2.34,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-16.28,"profit":false},{"date":"2023-12-31","value":93.27,"profit":true}] |
Income After Taxes | (20.43M) | (37.49M) | 117.12M | (233.57M) | 51.38M | [{"date":"2019-12-31","value":-17.44,"profit":false},{"date":"2020-12-31","value":-32.01,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-199.43,"profit":false},{"date":"2023-12-31","value":43.87,"profit":true}] |
Income From Continuous Operations | (20.43M) | (37.49M) | 117.12M | (233.57M) | (307.02M) | [{"date":"2019-12-31","value":-17.44,"profit":false},{"date":"2020-12-31","value":-32.01,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-199.43,"profit":false},{"date":"2023-12-31","value":-262.14,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (20.43M) | (37.49M) | 116.88M | (233.57M) | 51.38M | [{"date":"2019-12-31","value":-17.47,"profit":false},{"date":"2020-12-31","value":-32.08,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-199.83,"profit":false},{"date":"2023-12-31","value":43.96,"profit":true}] |
EPS (Diluted) | 0.01 | 0.12 | 0.88 | 0.97 | 0.81 | [{"date":"2019-12-31","value":1.44,"profit":true},{"date":"2020-12-31","value":12.46,"profit":true},{"date":"2021-12-31","value":90.72,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":83.51,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
SHC | |
---|---|
Cash Ratio | 1.57 |
Current Ratio | 2.88 |
Quick Ratio | 2.61 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
SHC | |
---|---|
ROA (LTM) | 7.68% |
ROE (LTM) | 16.70% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
SHC | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.85 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.15 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
SHC | |
---|---|
Trailing PE | 52.60 |
Forward PE | 16.23 |
P/S (TTM) | 3.32 |
P/B | 7.92 |
Price/FCF | 63 |
EV/R | 5.15 |
EV/Ebitda | 12.42 |
PEG | 1.35 |
Sotera Health Co (SHC) share price today is $12.99
Yes, Indians can buy shares of Sotera Health Co (SHC) on Vested. To buy Sotera Health Co from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SHC stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Sotera Health Co (SHC) via the Vested app. You can start investing in Sotera Health Co (SHC) with a minimum investment of $1.
You can invest in shares of Sotera Health Co (SHC) via Vested in three simple steps:
The 52-week high price of Sotera Health Co (SHC) is $17.44. The 52-week low price of Sotera Health Co (SHC) is $10.71.
The price-to-earnings (P/E) ratio of Sotera Health Co (SHC) is 52.6
The price-to-book (P/B) ratio of Sotera Health Co (SHC) is 7.92
The dividend yield of Sotera Health Co (SHC) is 0.00%
The market capitalization of Sotera Health Co (SHC) is $3.72B
The stock symbol (or ticker) of Sotera Health Co is SHC